UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039754
Receipt number R000045339
Scientific Title Muscle mass and outcomes of critically ill patients
Date of disclosure of the study information 2020/06/01
Last modified on 2024/03/12 10:20:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Muscle mass and outcomes of critically ill patients

Acronym

Muscle mass and outcomes of critically ill patients

Scientific Title

Muscle mass and outcomes of critically ill patients

Scientific Title:Acronym

Muscle mass and outcomes of critically ill patients

Region

Japan


Condition

Condition

Patients admitted in the ICU

Classification by specialty

Medicine in general Surgery in general

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To analyze the influence of muscle mass to outcomes in patients admitted in the ICU.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mortality (ICU, Hospital)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients admitted in the ICU

Key exclusion criteria

Insufficient information about body wight and height

Target sample size

50000


Research contact person

Name of lead principal investigator

1st name Nobuto
Middle name Nakanishi
Last name Nakanishi

Organization

The university of Tokushima

Division name

Emergency and critical care medicine

Zip code

770-8503

Address

2-50-1 Kuramoto Tokushima

TEL

0886339347

Email

nobuto_nakanishi@yahoo.co.jp


Public contact

Name of contact person

1st name Nobuto
Middle name
Last name Nakanishi

Organization

Tokushima University Hospital

Division name

2-50-1 Kuramoto Tokushima

Zip code

770-8503

Address

Tokushima

TEL

0886339347

Homepage URL


Email

nobuto_nakanishi@yahoo.co.jp


Sponsor or person

Institute

The university of Tokushima, emergency and critical care medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Trial Center for Developmental therapeutics, Tokushima University Hospital

Address

2-50-1 Kuramoto Tokushima

Tel

0886339347

Email

awachiken@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 01 Day


Related information

URL releasing protocol

https://www.mdpi.com/2079-9721/12/2/30

Publication of results

Published


Result

URL related to results and publications

https://www.mdpi.com/2079-9721/12/2/30

Number of participants that the trial has enrolled

3916

Results

Regarding BMI, in-hospital mortality was 36.9%, 29.8%, 26.7%, and 27.9% in patients who were underweight, normal weight, overweight, and obese, respectively (p < 0.01).

Results date posted

2024 Year 03 Month 12 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2024 Year 01 Month 16 Day

Baseline Characteristics

The inclusion criteria were age more than or equal to 18 years and a diagnosis of sepsis or septic shock.

Participant flow

Retrospective study in patients admitted in the intensive care unit

Adverse events

None

Outcome measures

BMI and calculated lean body mass

Plan to share IPD

None

IPD sharing Plan description

None


Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 03 Month 10 Day

Date of IRB

2020 Year 06 Month 04 Day

Anticipated trial start date

2020 Year 06 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry

2025 Year 03 Month 31 Day

Date trial data considered complete

2025 Year 03 Month 31 Day

Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2020 Year 03 Month 10 Day

Last modified on

2024 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045339


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name